Health

Is the UK Ready to Fight Off Omicron Virus?

Omicron Virus: The year 2019 witnessed the emergence of a new virus that was previously known to a very limited number of people. Termed as SARS-Covid 2, the virus was first identified in Wuhan, China after which it quickly assumed the intensity of a pandemic that has continued to date.

The toll took on the health and life of people worldwide and continues to do is beyond repair. According to the WHO, the total number of people that have lost their lives to the virus is around 5,324,243. Vaccines act as prophylactic measures and reduce the intensity of the disease. But the disease can still occur despite vaccines and prophylactic measures.

What does it do to the Human Body?

The virus has spike proteins on its surface that attach themselves to the ACE-2 receptors of the human body and enter our system. Once inside it settles in the cells lining the nose, sinus, cavity and throat, it begins replicating. After paralyzing the defence mechanism of the body, it starts its inflammatory reactions on the vital organs of the body.

Usually, it is airborne and carried with droplets of mucus passed through sneezing or coughing. But recent studies have shown that contaminated surfaces like doorknobs and railings of stairs can aid in spreading the infection. The entire world is waiting on the results of clinical trials going on with Ivermectin and Hydroxychloroquine to see if these two medicines can become the possible cure for Covid infections.

What is a variant?

Every virus changes and evolves in time as it spreads among people. Every time a virus replicates, there is a potential for change in its original structure. The changes in structure are defined as mutations. A virus with more than one mutation is referred to as a variant.

The WHO had previously identified a few variants of the SARS Covid virus and nomenclature them on the basis of Greek letters for the purpose of simplification. Alpha, Beta Gamma and Delta were some of the initial variants of the Covid virus. The delta variant, popularly known as the second Covid wave, was previously identified as the variant of concern with preventive measures taken to limit the infection. This was until Omicron was identified as a new variant.

A word about Omicron

Omicron was first brought to the attention of the WHO on 24th November 2021. By 26th November 2021, it was declared a Variant of Concern. The variant of Concern is the term used for mutant variants that have an increased tendency for transmission and virulence.

In simple words, Omicron has the probability of increased transmissibility and severity with reduced chances of vaccine-induced protection from the severity of the disease. The Delta variant too has been declared a Variant of Concern. While delta has 18 mutations in the spike protein, Omicron has over 30 of them.

Because of this, it is conjectured to be more contagious than other variants. Additionally, the increased mutations allow more escape routes and make it more immune to vaccine-induced antibodies.

What is the current status of the Omicron virus in the UK?

There have been a total of 817 cases of Omicron variant identified in the UK so far. Omicron has established itself in the UK spreading as far as parts of Northern Ireland. West Northamptonshire and parts of London like Croydon, Hackney and Newham have been declared the most affected areas.

However, the true number of cases may be significantly higher than recorded numbers. A high number of Covid Markers i.e. unconfirmed cases has also been recorded. This has led to the ministry of the UK passing some stern measures like:-

-Introducing plan B restrictions in accordance with the Covid situation

-Covid passports (mandatory) in large venues with huge crowds

– Working from home

Are these enough?

Scientists from the London School of Hygiene and Tropical Medicine have warned that the UK will face a substantial wave of the Omicron virus should these rules not be taken seriously. According to health experts, Omicron is a big hindrance to the path of the virus that was slowly decreasing downwards from a pandemic and inching towards an epidemic.

Discussion is still ongoing regarding the impact it is going to have on hospitals. If the variant virus does accelerate in intensity, unvaccinated people, children and people with a poor immune response to the vaccine will be most hit by it. Hospitals and healthcare providers who are already overworked and exhausted will be further affected by the situation.

What do researchers have to say about this?

In a study conducted to research Covid’s Variants of Concern, it was found that households and contacts had a higher risk of transmission from Omicron in comparison to the Delta variants. Secondary attack rates were influenced by the improved ascertainment around Omicron virus’s positive cases.

The data quality of these studies was insufficient to adjust for the vaccination status or prior infection status of the contacts. The studies proved one thing: that the Omicron virus if it continues to grow at the current rate, can reach parity with Delta cases by mid-December and assume the proportions of a third wave.

What is the plan of action regarding treatment options?

There is no evidence of the fact as yet but preliminary analyses are indicative of a three to eightfold increased risk of re-infection with the Omicron variant. Research is still ongoing regarding the neutralization data from published international and internal UK studies.

But across the 5 preliminary live virus studies, there was noticed a 20 to 40 fold reduction in neutralizing activities by Pfizer 2 dose vaccine sera for Omicron virus compared to earlier strains. The activity was tenfold less as compared to the Delta response to the virus.

An even greater reduction in activity was noticed for the AZ 2 dose sera while for higher proportions of such sera neutralization activity was too less than the limit of quantification to provide satisfactory results. The mRNA dose resulted in increased neutralizing activity irrespective of primary vaccination type. There was also an increase in the proportion of samples above the limit of quantification.

Proving its superiority over the previous sera, most importantly, the early estimates of the vaccine effectiveness against symptomatic infection found significantly lower effectiveness against Omicron virus in comparison to Delta. But a moderate to high vaccine effectiveness was noticed in the period after a booster dose.

The common link all studies are pointing at

Britain’s health authorities have declared open bookings for booster vaccines. The NHS England has declared around 3.5 million English citizens out of a total of 7.5 million citizens of age group 30-39 years eligible for Covid booster vaccine.

This booster program since the day of introduction is accelerating at a rapid rate with more than 22 million people have received the booster vaccine before Christmas. The Joint Committee on Vaccination and Immunization with the health ministry have all urged people to come forward and get their booster vaccination.

All reports and analyses point out the effectiveness of booster vaccination against fighting the Omicron virus.

What is Booster Vaccination?

A booster vaccine is an additional dose of vaccine given to a person who has already completed the two doses of vaccination. It is designed to help people maintain their immunity for a longer period of time. The Centre for Disease Control and Prevention usually recommends the booster if you have received the Johnson and Johnson vaccine dose two months prior.

People who have received both shots of either Moderna or Pfizer vaccine two months prior are also eligible for the booster dose. The FDA has authorised 3 vaccine boosters (Pfizer, Moderna and Johnson and Johnson) and determined that it is safe to get any of these 3 booster doses even if you have taken a different brand in your initial dose. The NHS UK has included the following groups of people who are eligible for a government-funded booster dose

– People of age of 30 years or above with a health condition that makes them susceptible to Covid

– Frontline health and social workers with people living and working in care homes

– People aged 16 and over are the main carrier for people at high risk to Covid or who live with someone at high risk to Covid.

– Pregnant women and in the above groups are also included in the eligibility criteria

Is it the same as that of an additional dose?

An additional dose or a third dose is given to people with moderate to severely compromised immune systems to help improve their response to the initial vaccine. Before the advent of the Johnson and Johnson vaccine, it was referred to as the third dose.

But the Johnson and Johnson vaccine being a single-dose vaccine, is now referred to as ‘additional dose’. It is different from the Covid-booster in the sense booster is given after completion of vaccine series but the additional dose is chiefly meant for immunocompromised individuals.

People undergoing active cancer treatment especially for blood, those having undergone an organ transplant or stem cell transplant and those with other immunosuppressive diseases like HIV or DiGeorge syndrome are eligible for the additional dose.

Take-Home Factor

Omicron Virus, despite the stir it has created, is new to the virus world with research ongoing regarding its pathways and a possible cure. Owing to the damage caused by the original virus and its variants, there are a lot of hyped news and unresearched claims circulating as a possible treatment regimen.

The UK has paved the path for research and treatment by introducing vaccines like Pfizer, Johnson and Johnson, Moderna and Oxford. But the list of FDA approved medications is still very small. Even medications like Ivermectin and Hydroxychloroquine are still permitted to be used only for clinical trials and not for public use.

Read more about Comparative Study on Ivermectin and HCQ. It is important to increase the supply of vaccines with their booster shots so more people can benefit from them. The government needs to conduct further research trials for newer drugs as a possible option along with spreading awareness among the public.

Also Check:

Thailand Bans Travelers from Eight Africa Nations Over

Governments Worldwide Panic Over Omicron Covid Variant

Omicron Covid-19 Variant May Hinder Thailand’s Reopening

Former South Korean President Park Sentenced to Eight

Health

Report Causes Pfizer Stock to Climb Approximately $1 Billion Acquired by Starboard

(VOR News) – According to a rumor that activist investor Pfizer Starboard Value has taken a holding in the struggling pharmaceutical business that is expected to be worth around one billion dollars, the stock of Pfizer (PFE) is on the increase in premarket trading on Monday.

This comes after the report was made public. The report was made available to the general public following this. Starboard Value was successful in moving forward with the acquisition of the position.

Starboard is said to have approached Ian Read, a former chief executive officer of Pfizer, and Frank D’Amelio, a former chief financial officer, in order to seek assistance with its goals of boosting the performance of the company, according to the Wall Street Journal. Read and D’Amelio are both former Pfizer executives.

The purpose of this is to facilitate the accomplishment of its objectives, which include enhancing the overall performance of the firm.

In their previous jobs, D’Amelio and Read were chief financial officers.

It is stated in the report that the hedge fund is of the opinion that Pfizer, which is currently being managed by Albert Bourla, who succeeded Read as Chief Executive Officer (CEO) in 2019, does not demonstrate the same level of mergers and acquisitions (M&A) discipline that Read did. Bourla took over for Read in 2019. Read was succeeded by Bourla in the year 2019.

Pfizer, a multinational pharmaceutical conglomerate, has made substantial investments in the acquisition of more companies that are involved in the research and development of cancer medicines.

These businesses have been acquired for billions of dollars. The biotechnology company Seagen, which was acquired by Pfizer in the previous year for a price of $43 billion, is included in this category. One of the businesses that can be classified as belonging to this category is Seagen.

In spite of the fact that the S&P 500 Index experienced a 21% increase in 2024.

No major trading occurred in Pfizer stock that year.

Due to the fact that the demand for Pfizer’s COVID-19 vaccines fell after the firm reached its pandemic peak in 2021, the share price of the corporation has decreased by over fifty percent since that time.

This drop has occurred ever since the company’s shares reached their maximum peak, which was during the time that this decline occurred. Not only have they not changed at all, but they have also remained essentially stable. This is in contrast to the S&P 500, which has gained 21% since the beginning of this year.

Recently, the corporation was forced to take a hit when it decided to recall all of the sickle cell illness medications that it had distributed all over the world.

Fears that the prescription could lead patients to experience severe agony and possibly even death were the impetus for the decision to recall the product. In spite of the fact that Pfizer’s stock is increasing by almost three percent as a result of the news that followed the company’s decision, this is the circumstance that has come about.

SOURCE: IPN

Health

New Study Reveals Drinking Soda Pop Increases the Risk of Stroke

If you drink too much soda, fruit juice and coffee, beware!

A recent report from global research indicates that excessive consumption of coffee or soda pop is associated with an increased risk of stroke, although the intake of black and green tea is correlated with a reduced risk. Excessive consumption of soda pop or coffee warrants caution!

Recent research indicates that it may substantially elevate the risk of stroke.

Consuming four cups of coffee daily elevates the risk of stroke, according to studies, although ingesting 3-4 cups of black or green tea daily typically offers protection against stroke. Additionally, consume more coffee; it may reduce your risk of mortality.

Recent findings from global research studies co-led by the University of Galway and McMaster University, alongside an international consortium of stroke researchers, indicate that soda, encompassing both sugar-sweetened and artificially sweetened variants such as diet or zero sugar, is associated with a 22 percent heightened risk of stroke. The risk escalated significantly with the consumption of two or more of these beverages daily.

Stroke Risk Fizzy Drinks and Soda Pop

The correlation between fizzy drinks consumption and stroke risk was most pronounced in Europe, the Middle East, Africa, and South America. Women exhibit the most elevated risk of stroke from bleeding (intracranial hemorrhage) associated with fruit juice beverages. Consuming over 7 cups of water daily diminishes the likelihood of stroke due to a clot.

Researchers observed that numerous items advertised as fruit juice are derived from concentrates and have added sugars and preservatives, potentially negating the advantages often associated with fresh fruit and instead elevating stroke risk.

Fruit juice beverages were associated with a 37 percent heightened risk of stroke resulting from bleeding (intracranial hemorrhage). Consuming two of these beverages daily increases the risk thrice.

Consuming over four cups of coffee daily elevates the risk of stroke by 37 percent, although lower consumption levels do not correlate with stroke risk. Conversely, tea consumption was associated with an 18-20 percent reduction in stroke risk. Additionally, consuming 3-4 cups daily of black tea, such as Breakfast and Earl Grey varieties, excluding green and herbal teas, was associated with a 29 percent reduced risk of stroke.

Consuming 3-4 cups of green tea daily was associated with a 27 percent reduction in stroke risk. Notably, the addition of milk may diminish or inhibit the advantageous effects of antioxidants present in tea. The lower risk of stroke associated with tea consumption was negated for individuals who added milk.

Disclaimer: This article is intended solely for informational reasons and should not be considered a replacement for professional medical counsel. Consistently consult your physician regarding any inquiries pertaining to a medical problem.

Starbucks Faces Sales Decline Amid Price Fatigue and Rising Competition

Starbucks Faces Sales Decline Amid Price Fatigue and Rising Competition

Health

Following a Diagnosis of Breast Cancer, What Else Should You Know?

(VOR News) – Even though breast cancer affects one in eight American women, receiving a diagnosis can make a woman feel isolated.

Experts in breast cancer from the American College of Physicians (ACS) advise patients on how to manage their disease so that they may better cope with this awful information.

First, the kind and stage of breast cancer dictates the course of your care.

In addition to immunotherapy and chemotherapy, there are various surgical options available for the treatment of breast cancer.

Women of African descent are disproportionately affected by triple-negative breast cancer, an extremely aggressive form of the disease that has never proven easy to treat.

According to the American Cancer Society, pembrolizumab (Keytruda), an immunotherapy, has been shown to be helpful when combined with chemotherapy and is currently the recommended course of treatment for certain combinations of triple-negative breast cancer.

In her presentation, Dr. Katharine Yao said, “It’s really important that the patient and physician discuss the patient’s preferences and values when deciding what type of treatment to pursue and that they have an honest, individualized discussion with their care team.”

She is currently responsible for developing breast cancer treatment recommendations for more than 575 hospitals and institutions nationwide in her role as chair of the American College of Surgeons’ National Accreditation Program for Breast Institutions (NAPBC).

Yao, vice chair of research at Endeavor Health NorthShore Hospitals in New York, pointed out that each decision made about a patient’s treatment plan should take her preferences and diagnosis into consideration.

She ought to think about whether she would prefer a mastectomy—a surgical procedure that involves removing the entire breast with or without reconstruction—or a lumpectomy, which involves a surgical procedure that spares part of the breast tissue.

She stated that “the breast cancer you have may be very different from the breast cancer you hear about in your neighbor, colleague, or friend” in a press release issued by the American Cancer Society (ACS).

“Consider that while discussing breast cancer with others.”

Throughout your journey, it is critical that you look after your emotional health because having breast cancer may have a detrimental impact on your mental health.

“Getting a cancer diagnosis does not mean that everything in your life stops to be normal.” Director of the Fellowship in the Diseases of the Breast program at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas and state head of the American Cancer Society Commission on Cancer for Arkansas, Dr. Daniela Ochoa She thinks adding the burden of a cancer diagnosis and treatment to all the other pressures in life may be taxing.

“Managing stress and emotional health is vital component of a treatment plan.”

Ochoa recommends clinically trained psychologists and social workers who have assisted people in coping with cancer to anyone receiving treatment. Learning coping techniques might also be facilitated by joining cancer support groups or cancer wellness initiatives.

Breast cancer specialists say your care team is crucial.

The American Cancer Society (ACS) defines comprehensive care as having support at every stage of the procedure from surgeons, oncologists, patient navigators, nurses, social workers, psychologists, and other specialists.

After receiving a breast cancer diagnosis, women should see a surgeon or medical oncologist to explore their options; nevertheless, treatment shouldn’t be discontinued after just one appointment or after surgery is over.

Additionally, you can ask trustworthy friends or family members to accompany you to appointments and aid you with research or notes. They could serve as a network of support for you.

Yao stated in his talk that “one of the most important things is that patients should search out a team they have confidence in, that they trust will have their back when they need it, and a team they feel they can get access to and that will help them when they are in need.”

SOURCE: MP